Jason Brown
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Jason Brown
Jun 26, 2024, 15:22 |
Insight
Results from the NIAGARA Phase III trial
AztraZeneca released the results of the NIAGARA phase III trial, where INFINZI (durvalumab) showed EFS…
Jun 22, 2024, 02:24 |
Insight
Guru Sonpavde: ctDNA for Evaluating Minimal Residual Disease in Bladder Cancer
Guru Sonpavde, Phase I and GU Oncology Director at Advent Health Cancer Institute, posted on…
Jun 20, 2024, 05:06 |
Blog
Pedro C Barata: Check out the wonderful editorial led by Jason Brown
Jason Brown, GU Oncologist at University Hospitals, shared a post by Pedro C Barata, GU Med Oncologist…
Jun 1, 2024, 23:26 |
Blog
Vadim Koshkin: Our recent work highlighting a Grey Zone in metastatic urothelial carcinoma after enfortumab vedotin/pembrolizumab
Vadim Koshkin, Assistant Professor at University of California, San Francisco, shared a post on X/Twitter:…
May 8, 2024, 23:31 |
Blog
Pedro Barata named the Miggo family chair in cancer research University Hospitals
Jason Brown, GU Oncologist at University Hospitals, shared a post by Pedro Barata, Medical Oncologist…
All:
5
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube